ARS Pharmaceuticals, Inc.
← Back to SPRY Overview

ARS Pharmaceuticals, Inc. (SPRY)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-3.29

Financial Fundamentals

SPRYQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-12-31-29.76
2020-03-31-39.06
2020-06-30-32.89
2020-12-31-30.49
2021-03-31-83.90
2021-06-30-59.40
2021-09-30-14.68
2021-12-31-11.10
2022-03-31-11.35
2022-06-30-15.47
2022-09-30-18.80
2022-12-31-14.22
2023-03-31-10.17
2023-06-30-9.31
2023-09-30-5.91
2023-12-31-18.36
2024-03-31-21.52
2024-06-30-16.79
2024-09-30-18.13
2024-12-315.17
2025-03-31-8.99
2025-06-30-9.48
2025-09-30-4.83
2025-12-31-6.93
2026-03-31-3.29

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.